The Qorvo Omnia Platform
EUA Point of Care Approved
CLIA Waived

Omnia Instrument

The Qorvo Biotechnologies Omnia System is an EUA only Point-of-Care approved, CLIA-waived platform. The system is used to run Qorvo's proprietary BAW-based cartridges and provides fully automated data transfer capability.

SARS-CoV-2 Antigen Kit

The Omnia SARS-CoV-2 Antigen Kit is a BAW-based, EUA-approved assay for the detection of SARS-CoV-2 from nasal swabs. This simple 3-step workflow (with 1-minute of hands-on time and 20 minutes of run time) is sample direct and works only with the Omnia platform. Each kit comes with enough reagents to run 20 samples.

SARS-CoV-2 Control Kit

The Omnia SARS-CoV-2 Control Kit is a liquid-based control to be used as required for the Omnia SARS-CoV-2 Antigen test on the Omnia instrument. Each kit comes with enough solution to run 60 controls. Cartridges are not included.

SARS-CoV-2/Flu Combo Antigen Kit

The Omnia SARS-CoV-2/Flu Combo Antigen Kit is a BAW-based, EUA-approved assay for the detection of SARS-CoV-2 and Influenza A and B from nasal swabs. The simple 3-step workflow (with 1-minute of hands-on time and 20 minutes of run time) is sample direct and works only with the Omnia platform. Each kit comes with enough reagents to run 20 samples.

Coming Soon!

SARS-CoV-2/Flu Combo Control Kit

The Omnia SARS-CoV-2/Flu Combo Control Kit is a swab-based dry control to be used as required to run the Omnia SARS-CoV-2/Flu Combo Antigen test. Each kit comes with enough viral positive swabs to run 5 controls. Cartridges are not included.

Coming Soon!

For all new customers, a customer service representative will contact you within 24 hours to complete your purchase.

By ordering from the Qorvo Biotechnologies website, you accept our
Terms and Conditions.

Interested in our instrument lease program?
Contact us using the form below.